Literature DB >> 18024708

Scaling up antiretroviral therapy in developing countries: what are the benefits and challenges?

A Boulle, N Ford.   

Abstract

Mesh：

Year:  2007        PMID： 18024708      PMCID： PMC2598632          DOI： 10.1136/sti.2007.027748

Source DB:  PubMed          Journal:  Sex Transm Infect        ISSN： 1368-4973            Impact factor:   3.519


× No keyword cloud information.
  36 in total

Review 1.  HIV prevention before HAART in sub-Saharan Africa.

Authors:  Elliot Marseille; Paul B Hofmann; James G Kahn
Journal:  Lancet       Date:  2002-05-25       Impact factor: 79.321

2.  Dramatic improvement in survival among adult Brazilian AIDS patients.

Authors:  Jose Ricardo P Marins; Leda F Jamal; Sanny Y Chen; Marilisa B Barros; Esther S Hudes; Aristides A Barbosa; Pedro Chequer; Paulo R Teixeira; Norman Hearst
Journal:  AIDS       Date:  2003-07-25       Impact factor: 4.177

3.  Patents versus patients? Antiretroviral therapy in India.

Authors:  Diane V Havlir; Scott M Hammer
Journal:  N Engl J Med       Date:  2005-08-25       Impact factor: 91.245

4.  Determinants of mortality and nondeath losses from an antiretroviral treatment service in South Africa: implications for program evaluation.

Authors:  Stephen D Lawn; Landon Myer; Guy Harling; Catherine Orrell; Linda-Gail Bekker; Robin Wood
Journal:  Clin Infect Dis       Date:  2006-08-08       Impact factor: 9.079

5.  Community-based treatment of advanced HIV disease: introducing DOT-HAART (directly observed therapy with highly active antiretroviral therapy).

Authors:  P Farmer; F Léandre; J Mukherjee; R Gupta; L Tarter; J Y Kim
Journal:  Bull World Health Organ       Date:  2001       Impact factor: 9.408

6.  Preventing antiretroviral anarchy in sub-Saharan Africa.

Authors:  A D Harries; D S Nyangulu; N J Hargreaves; O Kaluwa; F M Salaniponi
Journal:  Lancet       Date:  2001-08-04       Impact factor: 79.321

7.  Malawi's contribution to "3 by 5": achievements and challenges.

Authors:  Edwin Libamba; Simon D Makombe; Anthony D Harries; Erik J Schouten; Joseph Kwong-Leung Yu; Olesi Pasulani; Eustice Mhango; John Aberle-Grasse; Mindy Hochgesang; Eddie Limbambala; Douglas Lungu
Journal:  Bull World Health Organ       Date:  2007-02       Impact factor: 9.408

8.  Predictors of long-term viral failure among ugandan children and adults treated with antiretroviral therapy.

Authors:  Moses R Kamya; Harriet Mayanja-Kizza; Andrew Kambugu; Sabrina Bakeera-Kitaka; Fred Semitala; Patricia Mwebaze-Songa; Barbara Castelnuovo; Petra Schaefer; Lisa A Spacek; Anne F Gasasira; Elly Katabira; Robert Colebunders; Thomas C Quinn; Allan Ronald; David L Thomas; Adeodata Kekitiinwa
Journal:  J Acquir Immune Defic Syndr       Date:  2007-10-01       Impact factor: 3.731

9.  Conservation of first-line antiretroviral treatment regimen where therapeutic options are limited.

Authors:  Catherine Orrell; Guy Harling; Stephen D Lawn; Richard Kaplan; Matthew McNally; Linda-Gail Bekker; Robin Wood
Journal:  Antivir Ther       Date:  2007

10.  Substitutions due to antiretroviral toxicity or contraindication in the first 3 years of antiretroviral therapy in a large South African cohort.

Authors:  Andrew Boulle; Catherine Orrel; Richard Kaplan; Gilles Van Cutsem; Matthew McNally; Katherine Hilderbrand; London Myer; Matthias Egger; David Coetzee; Gary Maartens; Robin Wood
Journal:  Antivir Ther       Date:  2007
View more
  6 in total

1.  Travelling far but staying close to home.

Authors:  Nicola Low; Sevgi Aral; Jackie A Cassell
Journal:  Sex Transm Infect       Date:  2007-12       Impact factor: 3.519

2.  Temporal changes in programme outcomes among adult patients initiating antiretroviral therapy across South Africa, 2002-2007.

Authors:  Morna Cornell; Anna Grimsrud; Lara Fairall; Matthew P Fox; Gilles van Cutsem; Janet Giddy; Robin Wood; Hans Prozesky; Lerato Mohapi; Claire Graber; Matthias Egger; Andrew Boulle; Landon Myer
Journal:  AIDS       Date:  2010-09-10       Impact factor: 4.177

3.  Cultural adaptation of a survey to assess medical providers' knowledge of and attitudes towards HIV/AIDS in Albania.

Authors:  Shane D Morrison; Vania Rashidi; Vilson H Banushi; Namrata J Barbhaiya; Valbona H Gashi; Clea Sarnquist; Yvonne Maldonado; Arjan Harxhi
Journal:  PLoS One       Date:  2013-03-27       Impact factor: 3.240

4.  Strategies for monitoring and evaluation of resource-limited national antiretroviral therapy programs: the two-phase design.

Authors:  Sebastien Haneuse; Bethany Hedt-Gauthier; Frank Chimbwandira; Simon Makombe; Lyson Tenthani; Andreas Jahn
Journal:  BMC Med Res Methodol       Date:  2015-04-07       Impact factor: 4.615

5.  What happens to patients on antiretroviral therapy who transfer out to another facility?

Authors:  Joseph Kwong-Leung Yu; Teck-Siang Tok; Jih-Jin Tsai; Wu-Shou Chang; Rose K Dzimadzi; Ping-Hsiang Yen; Simon D Makombe; Amon Nkhata; Erik J Schouten; Kelita Kamoto; Anthony D Harries
Journal:  PLoS One       Date:  2008-04-30       Impact factor: 3.240

6.  Self-reported adherence to highly active antiretroviral therapy in a tertiary hospital in Nigeria.

Authors:  Ekiuwa V Eribo; Omokhoa A Adeleye
Journal:  Ghana Med J       Date:  2020-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.